Geron shares rose 7% to $ 5.70, but not really excited reasons. Although this is a political victory - which poses no real knowledge or directly Geron chances of success - after a decade in this study come from the earth.
A new drug safety studies in humans have begun to be safe and effective in only ten random. Geron "stem cells at risk. And progress has been made Ice Age in this area, among other things, because embryonic stem cells in any political controversy, partly because the science is very, very difficult to in the United States Food and Drug Administration has begun, perhaps researchers warn. In 2001, he said, cell therapy is "at least a decade."
The emphasis on "at least", I think. These and other evaluation Geron my credulity is now almost embarrassing.
With the use of embryonic stem cells in treatment? Ten years of waiting for the sound more like another possibility. Science is slow, and very easy to forget all the political rhetoric.
No comments:
Post a Comment